Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

278 projects found matching your search criteria :

  1. Blood plasma microRNA profile as a basis for detecting Alzheimer's disease and dementia risk in pre-symptomatic individu...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Urszula Wojda

    Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

  2. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marta Krawczyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  3. Molecular profiling of soft tissue sarcomas in tumor and peripheral blood in terms of response to treatment and early de...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Piotr Rutkowski

    Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy

  4. "I like to move it, move it" – molecular dynamics-driven optimization of ligand residence time as an opportunity to impr...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: dr hab. Sabina Podlewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  5. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Błażej Rubiś

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  6. Compounds modulating function of telomeric proteins TRF1 and TRF2

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Maciej Bagiński

    Politechnika Gdańska, Wydział Chemiczny

  7. Prioritizing diagnostics and therapeutics of human prion diseases through integrative omics

    Call: JPND Call 2023 , Panel: NZ2

    Principal investigator: prof. Beata Sikorska

    Uniwersytet Medyczny w Łodzi

  8. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  9. The role of oxidative stress, inflammation, disorders of purine metabolism, urea cycle and angiogenesis at the molecular...

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Paulina Wigner-Jeziorska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  10. Tumor viscoelasticity as a central player in glioblastoma treatment - towards mechanopharmacology

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Pogoda

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego Polskiej Akademii Nauk

  11. The impact of physical activity on the gut-brain axis molecular adaptation to chronic stress

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Julia Morys

    Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach

  12. Innovative Small Molecule Inhibitors Targeting LAG-3 and MHCII Complex for Tumour Immunotherapy

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr Jacek Plewka

    Uniwersytet Jagielloński w Krakowie

  13. AI-based model for fast and label-free identification of BAALC overexpression in acute myeloid leukemia cells

    Call: PRELUDIUM 23 , Panel: NZ1

    Principal investigator: Paulina Laskowska

    Instytut Hematologii i Transfuzjologii

  14. Effect of Urolithin A on gut microbiota and intestinal integrity contributing to neuroprotective effects in a model of P...

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Olga Wojciechowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  15. Novel human topoisomerase II inhibitors as anticancer agents

    Call: PRELUDIUM 15 , Panel: NZ7

    Principal investigator: dr Barbara Kaproń

    Uniwersytet Medyczny w Lublinie, Wydział Nauk o Zdrowiu

  16. Comparative analysis of intrinsic molecular subtypes as defined by PAM50 of circulating, primary and metastatic tumour c...

    Call: PRELUDIUM 15 , Panel: NZ4

    Principal investigator: Marcin Braun

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  17. Dissecting of the novel mechanisms in multi-drug resistance associated with vault's proteins and translation initiation ...

    Call: SONATA BIS 8 , Panel: NZ7

    Principal investigator: dr hab. Witold Szaflarski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  18. Specific interactions of new antitumor unsymmetrical bisacridines, UAs, with DNA and ABC proteins and their potential to...

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: prof. Zofia Mazerska

    Politechnika Gdańska

  19. Identyfication of changes in expression profile of mRNAs and proteins in blood platelets, as potential molecular markers...

    Call: PRELUDIUM 17 , Panel: NZ7

    Principal investigator: dr Rafał Piotr Szelenberger

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  20. The use of olaparib and ATR / CHK1 kinase inhibitors as a targeted anti-cancer therapy based on synthetic lethality

    Call: SONATA BIS 9 , Panel: NZ7

    Principal investigator: dr hab. Aneta Katarzyna Rogalska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  21. Molecular mechanisms of interplay between RORγ/RORγT receptors and cyclin-dependent kinase inhibitor (AT7519). Analysis ...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Kaja Urszula Karaś

    Instytut Biologii Medycznej Polskiej Akademii Nauk

  22. Seeking for CB1 and CB2 receptor ligands among drugs, drug metabolites, and phytochemical compounds

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Adam Stasiulewicz

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  23. Identification of molecular mechanism of Escherichia coli response to antimicrobial blue light inactivation by genome-wi...

    Call: SONATINA 4 , Panel: NZ7

    Principal investigator: dr Aleksandra Małgorzata Rapacka-Zdończyk

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  24. Influence of modified maternal diet on the phenotype of offspring: behavioral and molecular correlations

    Call: ETIUDA 8 , Panel: NZ7

    Principal investigator: Kinga Gawlińska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  25. New multifunctional drug-like ligands focusing on molecular targets associated with the symptoms and causes of Alzheimer...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Anna Marta Pasieka

    Uniwersytet Jagielloński, Collegium Medicum

  26. Genomic profiling of circulating biomarkers and matched primary tumors from breast cancer patients

    Call: OPUS 20 (LAP) , Panel: NZ5

    Principal investigator: dr Aleksandra Markiewicz

    Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  27. Epidemiology and rapid spread of antimicrobial resistance amongAcinetobacter spp. strains in hospital units - analysis u...

    Call: PRELUDIUM BIS 2 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Chmielarczyk

    Uniwersytet Jagielloński, Collegium Medicum

  28. Molecular mechanism of the protective effect of swimming training on skeletal muscle atrophy and the course of amyotroph...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: prof. Wiesław Ziółkowski

    Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej